Learn how the FDA uses FAERS, Sentinel, and AI to monitor generic drugs after approval, ensuring safety and bioequivalence for millions of users.
View DetailsInternational pharmacovigilance harmonization unifies global drug safety monitoring through ICH guidelines, cutting delays and duplication. Despite progress, regional gaps remain - especially in low-income countries - threatening patient safety worldwide.
View Details